|
1
|
Yang L: Incidence and mortality of gastric
cancer in China. World J Gastroenterol. 12:17–20. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Herszényi L and Tulassay Z: Epidemiology
of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci.
14:249–258. 2010.PubMed/NCBI
|
|
4
|
Choi AH, Nelson RA, Merchant SJ, Kim JY,
Chao J and Kim J: Rates of lymph node metastasis and survival in
T1a gastric adenocarcinoma in Western populations. Gastrointest
Endosc. 83:1184–1192.e1. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Takahashi T, Saikawa Y and Kitagawa Y:
Gastric cancer: Current status of diagnosis and treatment. Cancers
(Basel). 5:48–63. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hutvágner G and Zamore PD: A microRNA in a
multiple-turnover RNAi enzyme complex. Science. 297:2056–2060.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kwak PB, Iwasaki S and Tomari Y: The
microRNA pathway and cancer. Cancer Sci. 101:2309–2315. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J
and Sung JJ: MicroRNA dysregulation in gastric cancer: A new player
enters the game. Oncogene. 29:5761–5771. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shah NR and Chen H: MicroRNAs in
pathogenesis of breast cancer: Implications in diagnosis and
treatment. World J Clin Oncol. 5:48–60. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cheng D, Zhao S, Tang H, Zhang D, Sun H,
Yu F, Jiang W, Yue B, Wang J, Zhang M, et al: MicroRNA-20a-5p
promotes colorectal cancer invasion and metastasis by
downregulating Smad4. Oncotarget. 7:45199–45213. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang Z, Song Q, Zeng R, Li J, Li J, Lin
X, Chen X, Zhang J and Zheng Y: MicroRNA-218 inhibits EMT,
migration and invasion by targeting SFMBT1 and DCUN1D1 in cervical
cancer. Oncotarget. 7:45622–45636. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Han SY, Han HB, Tian XY, Sun H, Xue D,
Zhao C, Jiang ST, He XR, Zheng WX, Wang J, et al: MicroRNA-33a-3p
suppresses cell migration and invasion by directly targeting PBX3
in human hepatocellular carcinoma. Oncotarget. 7:42461–42473. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao JJ, Chen PJ, Duan RQ, Li KJ, Wang YZ
and Li Y: miR-630 functions as a tumor oncogene in renal cell
carcinoma. Arch Med Sci. 12:473–478. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu C, Li M, Zhang L, Bi Y, Wang P, Li J
and Jiang X: MicroRNA-205 suppresses the invasion and
epithelial-mesenchymal transition of human gastric cancer cells.
Mol Med Rep. 13:4767–4773. 2016.PubMed/NCBI
|
|
16
|
Liu GH, Liu YH, Yang Z, Zhu AL and Zhao
CL: MicroRNA-524-5p suppresses the growth and invasive abilities of
gastric cancer cells. Oncol Lett. 11:1926–1932. 2016.PubMed/NCBI
|
|
17
|
Tao S, Liu YB, Zhou ZW, Lian B, Li H, Li
JP and Zhou SF: MiR-3646 promotes cell proliferation, migration,
and invasion via regulating G2/M transition in human breast cancer
cells. Am J Transl Res. 8:1659–1677. 2016.PubMed/NCBI
|
|
18
|
Kwon SJ: Evaluation of the 7th UICC TNM
staging system of gastric cancer. J Gastric Cancer. 11:78–85. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li YJ, Ping C, Tang J and Zhang W:
MicroRNA-455 suppresses non-small cell lung cancer through
targeting ZEB1. Cell Biol Int. 40:621–628. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chai J, Wang S, Han D, Dong W, Xie C and
Guo H: MicroRNA-455 inhibits proliferation and invasion of
colorectal cancer by targeting RAF proto-oncogene
serine/threonine-protein kinase. Tumour Biol. 36:1313–1321. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cheng CM, Shiah SG, Huang CC, Hsiao JR and
Chang JY: Upregulation of miR-455-5p by the TGF-β-SMAD signalling
axis promotes the proliferation of oral squamous cancer cells by
targeting UBE2B. J Pathol. 240:38–49. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
MicroRNA-455 important in chondrogenesis.
Bonekey Rep. 1:1652012.PubMed/NCBI
|
|
24
|
Wu C, Dong S and Li Y: Effects of
miRNA-455 on cardiac hypertrophy induced by pressure overload. Int
J Mol Med. 35:893–900. 2015.PubMed/NCBI
|
|
25
|
Zhang H, Guan M, Townsend KL, Huang TL, An
D, Yan X, Xue R, Schulz TJ, Winnay J, Mori M, et al: MicroRNA-455
regulates brown adipogenesis via a novel HIF1an-AMPK-PGC1α
signaling network. EMBO Rep. 16:1378–1393. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hu Q, Gong JP, Li J, Zhong SL, Chen WX,
Zhang JY, Ma TF, Ji H, Lv MM, Zhao JH and Tang JH: Down-regulation
of miRNA-452 is associated with adriamycin-resistance in breast
cancer cells. Asian Pac J Cancer Prev. 15:5137–5142. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pavelić K, Kolak T, Kapitanović S,
Radosević S, Spaventi S, Kruslin B and Pavelić J: Gastric cancer:
The role of insulin-like growth factor 2 (IGF 2) and its receptors
(IGF 1R and M6-P/IGF 2R). J Pathol. 201:430–438. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gryko M, Kiśluk J, Cepowicz D, Zińczuk J,
Kamocki Z, Guzińska-Ustymowicz K, Pryczynicz A, Czyżewska J, Kemona
A and Kędra B: Expression of insulin-like growth factor receptor
type 1 correlate with lymphatic metastases in human gastric cancer.
Pol J Pathol. 65:135–140. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gao Y, Cui J, Xi H, Shen W, Zhang K, Li J,
Liang W, Hu C, Wei B and Chen L: Association of prognosis with
insulin-like growth factor receptor type I expression in gastric
cancer patients: A meta-analysis. Zhonghua Wei Chang Wai Ke Za Zhi.
18:1051–1055. 2015.(In Chinese). PubMed/NCBI
|
|
30
|
Matsubara J, Yamada Y, Nakajima TE, Kato
K, Hamaguchi T, Shirao K, Shimada Y and Shimoda T: Clinical
significance of insulin-like growth factor type 1 receptor and
epidermal growth factor receptor in patients with advanced gastric
cancer. Oncology. 74:76–83. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ge J and Chen Z, Huang J, Yuan W, Den Z
and Chen Z: Silencing insulin-like growth factor-1 receptor
expression inhibits gastric cancer cell proliferation and invasion.
Mol Med Rep. 11:633–638. 2015.PubMed/NCBI
|
